---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-003495"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T07:58:32.071993+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech shareholders approve 1.725M share increase to 2019 equity plan

## Summary
- Shareholders approved amendment to 2019 Equity Incentive Compensation Plan increasing share reserve by 1,725,000 shares.
- Fungible share pool provisions removed; incentive stock option limit raised from 171,429 to 300,000 shares.
- All seven director nominees elected: Chypyha, Liu, MacDonald, Marshall, Nijhawan, Olson, Sistilli.
- Advisory vote on executive compensation approved with 2,215,325 for, 178,016 against.
- MNP LLP appointed as independent auditor for fiscal year ending September 30, 2025.

## SEC filing metadata
- accession: 0001171843-25-003495
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000117184325003495/0001171843-25-003495-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000117184325003495/f8k_052825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-003495
- JSON: https://secwatch.observer/filing/0001171843-25-003495.json
- Plain text: https://secwatch.observer/filing/0001171843-25-003495.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.